2017
DOI: 10.5152/tjbh.2016.3351
|View full text |Cite
|
Sign up to set email alerts
|

Radiation Fibrosis Syndrome Imitating Breast Cancer Recurrence; A Case Report

Abstract: Nowadays, surgery, radiotherapy and chemotherapy are the most frequently used modalities in the treatment of breast cancer. It is very well-known that some severe complications may result from after these treatments. Early and late complications of radiotherapy are well known. The complications of radiation therapy may be seen in (early) or after three months (late-delayed) of periods. These complications may be related with direct or indirect effect of radiation. The radiation fibrosis syndrome is a progressi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 8 publications
0
6
0
Order By: Relevance
“…Animal grouping. Animals were randomly divided into 5 groups (10 mice each), Group 1: control not bearing tumor (received PBS i.p for 10 days), Group 2: Ehrlich solid tumor (EST) bearing mice (received PBS i.p for 10 days), Group 3: EST + γ-irradiation (1 Gy × 5) fractionated doses starting 2 days after tumor appearance (10 mm 3 ) and lasting for 5 days, Group 4: EST bearing mice receiving freshly prepared BL dissolved in PBS (6 mg/kg, i.p), daily for 10 days according to pilot study, starting once EST becomes 10 mm 3 . BL was purchased from Merck KGaA Co. (Darmstadt, Germany), Group 5: EST bearing mice received BL (as in group 4) 2 hours before γ-irradiation (as in group 3).…”
Section: In Vitro Studiesmentioning
confidence: 99%
See 1 more Smart Citation
“…Animal grouping. Animals were randomly divided into 5 groups (10 mice each), Group 1: control not bearing tumor (received PBS i.p for 10 days), Group 2: Ehrlich solid tumor (EST) bearing mice (received PBS i.p for 10 days), Group 3: EST + γ-irradiation (1 Gy × 5) fractionated doses starting 2 days after tumor appearance (10 mm 3 ) and lasting for 5 days, Group 4: EST bearing mice receiving freshly prepared BL dissolved in PBS (6 mg/kg, i.p), daily for 10 days according to pilot study, starting once EST becomes 10 mm 3 . BL was purchased from Merck KGaA Co. (Darmstadt, Germany), Group 5: EST bearing mice received BL (as in group 4) 2 hours before γ-irradiation (as in group 3).…”
Section: In Vitro Studiesmentioning
confidence: 99%
“… 1 However, from the clinical perspective, radiotherapy provides inadequate success due to the radioresistance of many tumors as well as the high risk of recurrence, and effects on normal cells may occur. 2 , 3 Radioresistance occurs as the microenvironment of solid tumors is hypoxic compared with normal tissue. 4 In addition, some tumors have either an intrinsic resistance to ionizing radiation or can attain this property through accumulation of genetic mutations causing an increased survival and proliferation.…”
Section: Introductionmentioning
confidence: 99%
“…In the case of potential radiation overexposure accidents, the use of chromosomal aberration assay is also advisable after radiotherapy, for example in the case of severe late toxicities. Radiation‐induced fibrosis occurring more than a decade after breast cancer therapy with the suspicion of recurrent breast tumour has been reported in the literature . Therefore, patients with the suspicion of tumour recurrence that has been precluded by biopsy may also benefit because further ionising load (X‐ray, CT scans) can be reduced.…”
Section: Discussionmentioning
confidence: 99%
“…[10] Histopathological analysis may reveal hyalinized fibrotic tissue with spotty hyalinizing necrosis infiltrating the striated muscular, adipose, vascular, and nervous tissues. [58] Immunohistochemistry may be used to differentiate between RIF and other pathologies of the primary tissue. [5]…”
Section: Clinical Manifestations Of Radiation Fibrosis Syndromementioning
confidence: 99%
“…[2] Subsequent fibrosis reduces tissue compliance and causes cosmetic and functional impairment that significantly impacts the QOL in the majority of cancer patients, and particularly those with head-and-neck (H and N) cancer. [5]…”
Section: Introductionmentioning
confidence: 99%